Makker V, Colombo N, Herraez AC, Monk BJ, et al. Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775. J Clin Oncol 2023;41:2904-2910.
PMID: 37058687